Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 182Breast 27Tumor-Agnostic 4Other 4Lymphoid 4Plasma cell 3Other hematologic neoplasm 3Myeloid 3Head & Neck 3Thoracic 1Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Uterine Neoplasms 1Leiomyoma 1

Interventions

Paclitaxel 575Carboplatin 520Cisplatin 347Bevacizumab 252pembrolizumab 226Gemcitabine 157Topotecan 128liposomal doxorubicin 127Cyclophosphamide 126olaparib 120Taxes 113Radiotherapy 110Docetaxel 94Brachytherapy 89Doxorubicin 84Drug Therapy 80niraparib 75Nivolumab 71Magnetic Resonance Spectroscopy 71Specimen Handling 65fludarabine 56Biopsy 55Hyperthermic Intraperitoneal Chemotherapy 53Filgrastim 52Letrozole 50Oxaliplatin 48durvalumab 47Immunoglobulin G 47atezolizumab 46Platinum 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Leuprolide × Gynecologic × Clear all
NCT00776074 2010-06-22

A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.

Takeda

Phase 2 Completed
80 enrolled
Gynecologic

Leiomyoma, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡